SOC Telemed Completes Acquisition by Patient Square Capital
/PRNewswire/ -- SOC Telemed, Inc. (NASDAQ: TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced...
Source: prnewswire.com
Steve Rubis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Steve Rubis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Steve Rubis Today - Breaking & Trending Today
SOC Telemed Stockholders Approve Acquisition by Patient Square Capital
/PRNewswire/ -- SOC Telemed, Inc. (NASDAQ: TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced...
Source: prnewswire.com
SOC Telemed Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
/PRNewswire/ -- SOC Telemed, Inc., (NASDAQ: TLMD), the largest national provider of acute care telemedicine, today announced its financial and operating...
Source: prnewswire.com
SOC Telemed to be Acquired by Patient Square Capital
/PRNewswire/ -- SOC Telemed, Inc. (NASDAQ: TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced...
Source: prnewswire.com
IP : Kuur Therapeutics Ltd - Athenex to Acquire Kuur Therapeutics to expand cell therapy development with off-the-shelf engineered CAR-NKT platform
Transformative, leading allogeneic NKT cell platform technology expands Athenex's cell therapy development capability Platform has broad applications based on transducing NKT cells with chimeric antigen receptors (CARs) and T cell receptors (TCRs) to target hematological and solid cancers, respectively Total potential consideration of $185 million, comprising $70 million upfront primarily in Athenex common stock, and $115 million in development milestones Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of...
Source: marketscreener.com